Karen Sims - Net Worth and Insider Trading

Karen Sims Net Worth

The estimated net worth of Karen Sims is at least $349,378 dollars as of 2025-04-26. Karen Sims is the Chief Medical Officer of Arbutus Biopharma Corp and owns about 106,194 shares of Arbutus Biopharma Corp (ABUS) stock worth over $349,378. Details can be seen in Karen Sims's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Sims has not made any transactions after 2025-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Karen Sims

To

Karen Sims Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karen Sims owns 1 companies in total, including Arbutus Biopharma Corp (ABUS) .

Click here to see the complete history of Karen Sims’s form 4 insider trades.

Insider Ownership Summary of Karen Sims

Ticker Company Transaction Date Type of Owner
ABUS Arbutus Biopharma Corp 2025-02-04 Chief Medical Officer

Karen Sims Latest Holdings Summary

Karen Sims currently owns a total of 1 stock. Karen Sims owns 106,194 shares of Arbutus Biopharma Corp (ABUS) as of February 4, 2025, with a value of $349,378.

Latest Holdings of Karen Sims

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABUS Arbutus Biopharma Corp 2025-02-04 106,194 3.29 349,378

Holding Weightings of Karen Sims


Karen Sims Form 4 Trading Tracker

According to the SEC Form 4 filings, Karen Sims has made a total of 2 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 19,348 shares on February 4, 2025, which brought Karen Sims around $63,461.

Insider Trading History of Karen Sims

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karen Sims Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karen Sims Ownership Network

Ownership Network List of Karen Sims

No Data

Ownership Network Relation of Karen Sims

Insider Network Chart

Karen Sims Owned Company Details

What does Arbutus Biopharma Corp do?

Who are the key executives at Arbutus Biopharma Corp?

Karen Sims is the Chief Medical Officer of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and General Counsel and CCO J. Christopher Naftzger .

Arbutus Biopharma Corp (ABUS) Insider Trades Summary

Over the past 18 months, Karen Sims made 2 insider transaction in Arbutus Biopharma Corp (ABUS) with a net sale of 23,706. Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 33,954 shares made by Michael J. Mcelhaugh , a net sale of 31,776 shares made by David C Hastings , and a net sale of 11,333 shares made by J. Christopher Naftzger .

In summary, during the past 3 months, insiders sold 76,654 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 76,654 shares. During the past 18 months, 119,597 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,597 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arbutus Biopharma Corp Insider Transactions

No Available Data

Karen Sims Mailing Address

Above is the net worth, insider trading, and ownership report for Karen Sims. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Karen Sims's mailing address is: Warminster Pa 18974.